Clinical Trial Update: PEG-IFN in HBV Patients With Incomplete Response to NA [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pegylated interferon in patients with chronic hepatitis B who have an incomplete response to nucleos(t)ide analogs; study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PEG-IFNα (pegylated interferon alfa)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED